ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1284

Sensitivity to Change of Patient Preference Outcome Measures for Pain in Trials of Patients with Knee Osteoarthritis

Matthew J. Parkes1, Michael J. Callaghan1, Terence W. O'Neill1 and David T. Felson1,2, 1Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, University of Manchester, Manchester, United Kingdom, 2Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Osteoarthritis, Outcome measures, patient outcomes and patient preferences

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects: Epidemiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose

A variety of pain and function instruments are often measured in osteoarthritis (OA) clinical trials. Instruments with maximal sensitivity to change are preferred as the primary measure in trials. Shown to be sensitive to change in rheumatoid arthritis, patient preference instruments, in which a patient nominates a painful activity to track, have not been tested in OA trials. Ideally, to compare the sensitivity to change of outcome measures, trials with a positive result need to be studied. We compared the sensitivity to change of pain and function self-report outcomes in 2 OA trials that reported statistically significant improvements in pain/functional status outcomes.

Methods

We used data from a controlled trial of a knee brace (BRACE; n = 126) and an uncontrolled trial of intraarticular steroid injection (TASK; n = 120). For both trials, eligible subjects had to meet ACR criteria for knee OA and have significant knee pain. In addition to completing KOOS and WOMAC questionnaires, and questions about overall knee pain, subjects were asked to nominate an activity that commonly caused them knee pain, and to rate pain during that activity throughout the trial. Standardised response means (SRMs) were generated for multiple time points in both trials, in the active treatment group alone, and comparing treatment to control, where possible. Additionally, we tested correlations between the study outcomes and an anchor variable: a 5-point likert scale of patient-perceived change in pain, using ordinal regression to determine the odds of an improvement in pain for a 1 SD increase in each pain outcome.

Results

Both trials reported a positive effect of the intervention on pain and function. Pain on nominated activity visual analogue score (VAS) produced SRMs that were at least as high as other pain outcomes, and usually higher (table 1). Sensitivity to change of the other outcomes was less consistent. Patient perceived improvement in pain was more strongly associated with pain on nominated activity than the other pain or function outcomes (table 2).

Conclusion

Pain on nominated activity may be an extremely sensitive outcome for OA trials, and appears more strongly associated with perceived pain improvement than other currently used outcome measures.

Table 1: Standardised Response Means (SRMs) for the TASK and BRACE Trials.

 

Outcome

BRACE Study – 6 week active vs. control treatment   difference: SRMs

BRACE Study – 6 week active treatment only: SRMs

BRACE Study – 12 week active treatment only: SRMs

TASK Study – Change at 1 week after   intra-articular steroid: SRMs

Pain on nominated activity VAS

-0.31

-0.85

-0.95

-1.13

Pain in last week VAS

-0.25

-0.86

-0.73

-1.07

Global pain VAS

–

–

–

-0.51

KOOS pain subscale

-0.16

-0.53

-0.73

-1.12

KOOS symptom subscale

-0.20

-0.62

-0.61

-0.94

KOOS activities of daily living subscale

-0.12

-0.54

-0.77

-1.04

WOMAC pain subscale

-0.13

-0.47

-0.63

-1.06

WOMAC stiffness subscale

-0.19

-0.53

-0.51

-1.17

WOMAC function subscale

-0.12

-0.54

-0.77

-1.04

 

Table 2: Association between Different Pain Outcomes and Patient Perceived Improvement in Pain. Odds Ratios Indicate Odds of Improvement in Patient Perceived Pain, for a 1 SD Improvement in the Outcomes Listed.

 

Outcome

BRACE Study – 6 week change, all persons pooled

BRACE Study – 12 week change, all persons pooled

TASK Study – Change at 1 week follow-up

Pain on nominated activity VAS

2.09

2.57

6.12

Pain in last week VAS

1.94

2.15

4.45

Global pain VAS

–

–

2.36

KOOS pain subscale

1.63

1.79

1.87

KOOS symptom subscale

1.64

1.62

1.88

KOOS activities of daily living subscale

1.67

1.70

1.86

WOMAC pain subscale

1.60

1.71

1.84

WOMAC stiffness subscale

1.57

1.56

1.79

WOMAC function subscale

1.67

1.70

1.86


Disclosure:

M. J. Parkes,
None;

M. J. Callaghan,
None;

T. W. O’Neill,
None;

D. T. Felson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sensitivity-to-change-of-patient-preference-outcome-measures-for-pain-in-trials-of-patients-with-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology